Acadia Healthcare Company Inc (ACHC) Expected to Announce Earnings of $0.59 Per Share

Equities research analysts predict that Acadia Healthcare Company Inc (NASDAQ:ACHC) will announce $0.59 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Eight analysts have issued estimates for Acadia Healthcare’s earnings. The lowest EPS estimate is $0.55 and the highest is $0.63. Acadia Healthcare reported earnings per share of $0.70 during the same quarter last year, which indicates a negative year over year growth rate of 15.7%. The firm is scheduled to report its next quarterly earnings results on Monday, July 29th.

On average, analysts expect that Acadia Healthcare will report full-year earnings of $2.20 per share for the current financial year, with EPS estimates ranging from $2.13 to $2.38. For the next financial year, analysts forecast that the business will post earnings of $2.47 per share, with EPS estimates ranging from $2.18 to $2.97. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research analysts that that provide coverage for Acadia Healthcare.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Tuesday, April 30th. The company reported $0.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.04. The firm had revenue of $760.60 million for the quarter, compared to the consensus estimate of $762.02 million. Acadia Healthcare had a negative net margin of 6.50% and a positive return on equity of 7.33%. The business’s revenue was up 2.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.52 earnings per share.

Several research analysts have recently issued reports on the stock. BMO Capital Markets upped their target price on shares of Acadia Healthcare from $33.00 to $36.00 and gave the stock a “market perform” rating in a research note on Wednesday, May 1st. BidaskClub upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Wednesday, May 1st. Deutsche Bank set a $32.00 target price on shares of Acadia Healthcare and gave the stock a “hold” rating in a research note on Thursday, May 2nd. ValuEngine upgraded shares of Acadia Healthcare from a “strong sell” rating to a “sell” rating in a research note on Wednesday, April 24th. Finally, Citigroup dropped their target price on shares of Acadia Healthcare from $43.00 to $38.00 and set a “buy” rating on the stock in a research note on Monday, March 4th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and three have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $36.80.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Private Capital Group LLC raised its holdings in shares of Acadia Healthcare by 67.3% during the first quarter. Private Capital Group LLC now owns 865 shares of the company’s stock valued at $25,000 after purchasing an additional 348 shares during the last quarter. Premia Global Advisors LLC purchased a new stake in Acadia Healthcare during the first quarter valued at approximately $28,000. Oregon Public Employees Retirement Fund increased its holdings in Acadia Healthcare by 2,686.1% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 897,973 shares of the company’s stock valued at $35,000 after buying an additional 865,743 shares during the last quarter. Cresset Asset Management LLC purchased a new stake in Acadia Healthcare during the first quarter valued at approximately $40,000. Finally, Advisor Group Inc. increased its holdings in Acadia Healthcare by 23.9% during the fourth quarter. Advisor Group Inc. now owns 3,039 shares of the company’s stock valued at $78,000 after buying an additional 587 shares during the last quarter.

Shares of NASDAQ ACHC traded up $0.16 during midday trading on Friday, hitting $32.92. The stock had a trading volume of 764,941 shares, compared to its average volume of 1,013,177. The company has a market cap of $2.93 billion, a PE ratio of 14.70, a P/E/G ratio of 1.76 and a beta of 0.70. Acadia Healthcare has a 52 week low of $24.27 and a 52 week high of $45.35. The company has a debt-to-equity ratio of 1.55, a quick ratio of 1.07 and a current ratio of 1.07.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

See Also: How Investors Use a Balance Sheet

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.